Form 4: Levi Strauss & Co. Director Joshua Prime Reports Acquisition of Class A Common Stock
SEC Form 4 Filing
Director Joshua Prime reports acquiring 118 shares of Levi Strauss & Co. Class A Common Stock due to dividend equivalent rights.
Summary
- On February 23, 2024, Joshua Prime, a director of Levi Strauss & Co., acquired 118 shares of Class A Common Stock.
- The acquisition was due to dividend equivalent rights (DER).
- The price per share was $0.00.
- Following the transaction, Prime directly owns 44,535 shares of Class A Common Stock.
- Some of the underlying Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to director compensation. The acquisition of shares by a director is generally viewed as a positive sign, but it's not a major event.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of shares through dividend equivalent rights, which is a common form of compensation.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals confidence from a director.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of transaction: Joshua Prime acquired 118 shares of Class A Common Stock. |
| 02/27/2024 | Date of signature: Form 4 signed by Priscilla Duncan-Tannous, Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.